These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 598422)

  • 41. Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine.
    Gundert-Remy U; Amann E; Hildebrandt R; Weber E
    Eur J Clin Pharmacol; 1983; 25(5):595-9. PubMed ID: 6662159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of clonidine and guanfacine in essential hypertension.
    Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
    Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are opioid receptors involved in the bradycardiac and hypotensive action of clonidine?
    Rhee HM; De Lapp JD
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):249S-254S. PubMed ID: 2843198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension.
    Campese VM; Romoff M; Telfer N; Weidmann P; Massry SG
    Kidney Int; 1980 Sep; 18(3):351-7. PubMed ID: 7007709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
    Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
    Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-response profiles of plasma growth hormone and vasopressin after clonidine challenge in man.
    Brown GM; Mazurek M; Allen D; Szechtman B; Cleghorn JM
    Psychiatry Res; 1990 Mar; 31(3):311-20. PubMed ID: 2333361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine.
    Fyhrquist F; Kurppa K; Huuskonen M
    Acta Med Scand; 1975 Jun; 197(6):457-61. PubMed ID: 1155220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats.
    Tibirica E; Feldman J; Bousquet P
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1062-6. PubMed ID: 2855238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonidine and carotid baroreflex in essential hypertension.
    Mancia G; Ferrari A; Gregorini L; Zanchetti A
    Hypertension; 1979; 1(4):362-70. PubMed ID: 541039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.
    Hamilton TC; Longman SD
    Br J Pharmacol; 1982 Jan; 75(1):13-21. PubMed ID: 6122478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of long-term administration of clonidine on plasma renin activity.
    De Wurstemberger B; Gysling E
    Can Med Assoc J; 1976 Dec; 115(11):1107-8. PubMed ID: 1000443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypotensive and alpha-adrenergic activities of 2-(2,3,6-trichlorophenylimino) and 2-(2,3-dichloro-6-methylphenylimino) imidazolidine, two potent derivatives of clonidine.
    de Jonge A; Timmermans PB; van Zwieten PA
    Br J Pharmacol; 1983 Mar; 78(3):479-87. PubMed ID: 6132639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic-pharmacodynamic modeling of the effects of clonidine on pain threshold, blood pressure, and salivary flow.
    Porchet HC; Piletta P; Dayer P
    Eur J Clin Pharmacol; 1992; 42(6):655-61. PubMed ID: 1623908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sedative and cardiovascular effects of clonidine and nitrazepam.
    Hossmann V; Maling TJ; Hamilton CA; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1980 Aug; 28(2):167-76. PubMed ID: 7398184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients.
    Mancia G; Ferrari A; Gregorini L; Parati G; Pomidossi G; Grassi G; Bertinieri G; Zanchetti A
    J Cardiovasc Pharmacol; 1981; 3(6):1193-202. PubMed ID: 6173518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
    Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
    JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
    Klein C; Morton N; Kelley S; Metz S
    J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of sustained-release and standard preparations of clonidine in essential hypertension.
    Fyhrquist F
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral presynaptic and central effects of clonidine, yohimbine and rauwolscine on the sympathetic nervous system in rabbits.
    Szabo B; Hedler L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):648-57. PubMed ID: 2615856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.